• Home >
  • Publications >
  • Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study

Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study

1 Dec 2015The Breast

DOI : 10.1016/j.breast.2015.09.002

Authors

D. Chocteau-Bouju, C. Chakiba, L. Mignot, N. Madranges, J.-Y. Pierga, P. Beuzeboc, N. Quenel-Tueux, V. Dieras, H. Bonnefoi, M. Debled, P. Cottu